Blog Read the latest perspectives from our team of subject matter experts and others Leading Health Plans Are Adopting AI to Transform Network OperationsHealth plans are under growing pressure to improve provider directory accuracy, accelerate roster processing, and prepare for a rapidly evolving regulatory environment. Leading organizations are responding by applying AI across… Continue reading → Read the article Post Topics:Artificial Intelligence Commercialization Drug Development Global Impact KOL Engagement Patient Representation Provider Data Post Industries:Digital Health Health Plans Pharmaceutical & Biotechnology Drug DevelopmentPatient Representation3 Ways CROs Can Expedite Clinical Trial Site SuccessClinical Research Organizations (CROs) play an important role in the success of clinical trials. They provide crucial resources, processes, and strategies to ensure that trials are conducted with the… Continue reading → Read the articleno KOL EngagementLet’s Get Personal: Four Benefits to Omnichannel StrategiesWith the proliferation of digital media, marketing in the healthcare industry has shifted from traditional tactics to an omnichannel approach. Omnichannel engagement for physician marketing is a powerful tool… Continue reading → Read the articleno KOL EngagementNurses: The Unsung Heroes in Pharma and BiotechHealthcare providers are often the first line of defense in ensuring that people receive the medical treatment they need. But nurses are often overlooked as a solution to addressing patient… Continue reading → Read the articleno KOL EngagementPatient RepresentationFour Ideas for Pharma to Maximize the Influence of Digital Opinion Leaders in MedicinePharmaceutical companies have long recognized the importance of engaging key opinion leaders (KOLs) to gain insight and support for clinical research, drug development, and medical education. With the rise… Continue reading → Read the articleno Drug DevelopmentPatient RepresentationData Networks & Guiding Clinical Trials – Six Metrics for Powering Trials to Reach Vulnerable Patient PopulationsFor clinical operations and development clinical feasibility teams, and patient representation leaders, as well as health economics and outcomes research (HEOR) teams, it is essential to understand the considerations when… Continue reading → Read the articleno KOL EngagementThree Ways Field Medical Teams Can Close Care Gaps and Increase Scientific Share of VoiceAs the primary interface between healthcare providers (HCPs) and pharmaceutical companies, medical science liaisons (MSLs) have a unique opportunity to engage with HCPs in clinical discussions and bridge care gaps… Continue reading → Read the articleno«‹78910111213›»
